Objectivs Enzyme/prodrug gene therapy provides a potential strategy for the treatment of glioma.Because of the limitations of using viral vectors for clinical application, we investigated the feasibility of cationicam...Objectivs Enzyme/prodrug gene therapy provides a potential strategy for the treatment of glioma.Because of the limitations of using viral vectors for clinical application, we investigated the feasibility of cationicamphiphile-mediated enzyme/prodrug gene transfer into C6 glioma cells. Methods Rat C6 glioma cells weretransfected with pUT599plasmid encoding the herpes simplex virus thymidine kinase (HSV-tk) gene via DOTAPand tested for chemosensitivity of prodrug ganciclovir (GCV). To demonstrate in vitro bystander effect, HSV-tkpositive cells were co-cultured with HSV-tk negative cells at varying proportions. Results DOTAP mediatedHSV-tk gene transfer into C6 cells showed 30%-40% of transfection efficiency. HSV-tk infected C6 glioma cellswere rendered sensitive to concentrations of GCV that were 3-4 logs lower than uninfected cells, with an IC05 of0.087μmol/L. In terms of the bystander effect, the viability of co-cultured cells decreased with increasingpopulations of HSV-tk positive cells after GCV treatment. Conclusion C6 cells were successfully transfected withthe HSV-tk gene via cationic amphiphile and displayed a strong bystander effect after GCV treatment. Cationicamphiphile - mediated HSV- tk/GCV chemosensitivity System may have promise as an intratumoral treatment forglioma.展开更多
Cancer enzymology is a promising filiation of bio-medical sciences. In thepast decades, enzymes, such as GST(glutathione S-transferase) , PKC(protein kinase C) , Topo(DNAtopoisomerases), TK(tyrosine kinase), CD (bacte...Cancer enzymology is a promising filiation of bio-medical sciences. In thepast decades, enzymes, such as GST(glutathione S-transferase) , PKC(protein kinase C) , Topo(DNAtopoisomerases), TK(tyrosine kinase), CD (bacterial cytosine deaminase), CPG2(carboxypeptidase G2) ,and PNP (purine nucleoside phosphorylase), have been known to bear close relations to cancer. Theirspecific expression and influence on the process of tumor initiation, promotion and progressionattract scientists to apply them as a biochemical marker of certain malignant tumor, a predictor ofresponse in cancer chemotherapy; to apply them to drug design, tumor prevention and as adjuvant toradiotherapy or surgery.展开更多
The enzyme-mediated elevation of reactive oxygen species(ROS)at the tumor sites has become an emerging strategy for regulating intracellular redox status for anticancer treatment.Herein,we proposed a camouflaged bioni...The enzyme-mediated elevation of reactive oxygen species(ROS)at the tumor sites has become an emerging strategy for regulating intracellular redox status for anticancer treatment.Herein,we proposed a camouflaged bionic cascaded-enzyme nanoreactor based on Ti_(3)C_(2)nanosheets for combined tumor enzyme dynamic therapy(EDT),phototherapy and deoxygenation-activated chemotherapy.Briefly,glucose oxidase(GOX)and chloroperoxidase(CPO)were chemically conjugated onto Ti_(3)C_(2)nanosheets,where the deoxygenation-activated drug tirapazamine(TPZ)was also loaded,and the Ti_(3)C_(2)-GOX-CPO/TPZ(TGCT)was embedded into nanosized cancer cell-derived membrane vesicles with high-expressed CD47(m_eTGCT).Due to biomimetic membrane camouflage and CD47 overexpression,m_eTGCT exhibited superior immune escape and homologous targeting capacities,which could effectively enhance the tumor preferential targeting and internalization.Once internalized into tumor cells,the cascade reaction of GOX and CPO could generate HClO for efficient EDT.Simultaneously,additional laser irradiation could accelerate the enzymic-catalytic reaction rate and increase the generation of singlet oxygen(~1O_(2)).Furthermore,local hypoxia environment with the oxygen depletion by EDT would activate deoxygenation-sensitive prodrug for additional chemotherapy.Consequently,m_eTGCT exhibits amplified synergistic therapeutic effects of tumor phototherapy,EDT and chemotherapy for efficient tumor inhibition.This intelligent cascaded-enzyme nanoreactor provides a promising approach to achieve concurrent and significant antitumor therapy.展开更多
Enzyme prodrug therapies(EPTs)have been intensively explored as attractive approaches to selective activation of systemically administered benign prodrugs by the exogenous enzymes or enzymes expressed at the desired t...Enzyme prodrug therapies(EPTs)have been intensively explored as attractive approaches to selective activation of systemically administered benign prodrugs by the exogenous enzymes or enzymes expressed at the desired target site,thus achieving localized,site-specific therapeutic effect.Many effective strategies(e.g.,antibody-,viral-,gene-,as well as polymer-directed EPT)have been developed for enzyme localization to locally activate systemically administered benign prodrugs.Nevertheless,intrinsic limitations(e.g.,complex intracellular environment and catalyst instability)make the practical application of EPT strategies a task that presents itself as highly challenging.As a promising alternative to natural enzyme,nanozyme has attracted substantial attention since its discovery in 2007,mainly due to the advantages of robust catalytic activity,high stability,low cost,and facile synthesis.Recently,nanozyme-activated prodrug strategies bring a new opportunity for targeted therapy,referred to as nanozyme-activating prodrug therapies.This review focuses on recently reported nanozyme-activated prodrug strategies,aiming to provide some new insights into the potential applications in site-specific drug synthesis.展开更多
Gold complexes have emerged as promising anticancer metallodrugs due to their efficient thioredoxin reductase(TrxR)inhibition,which disturbs the redox balance of cancer cells.However,in this model,the role of the liga...Gold complexes have emerged as promising anticancer metallodrugs due to their efficient thioredoxin reductase(TrxR)inhibition,which disturbs the redox balance of cancer cells.However,in this model,the role of the ligand(s)coordinated to gold is often overlooked.In this work,we present a series of tetrapyridyl Au(Ⅲ)complexes that exhibit thiol-induced release of a Au(Ⅰ)ion and a tetrapyridyl ligand.The formation of a free Au(Ⅰ)center is responsible for the expected TrxR inhibition.Additionally,the released ligand,which was visible in cells due to its intense blue fluorescence,showed excellent binding properties to the hERG potassium channel.Moreover,these ligands ended up in the lysosomes,resulting in significant lysosome damage.Altogether,the Au(Ⅲ)complexes presented in this work showed broad-spectrum anticancer properties,both in hypoxic 2D monolayers and 3D tumor spheroids.We suggest that the interaction of the released Au(Ⅰ)center and the tetrapyridyl ligand with two different protein targets may combine into prodrugs that overcome hypoxia-induced drug deactivation.展开更多
多数传统的经皮给药系统(traditional transdermal drug delivery system,TDDS)药物,由于化学稳定性差、油水分配系数不理想等,并不适合作为TDDS药物局部给药。而前体药物可以在皮肤组织经酶激活,代谢释放出具有活性物质的化合物。该文...多数传统的经皮给药系统(traditional transdermal drug delivery system,TDDS)药物,由于化学稳定性差、油水分配系数不理想等,并不适合作为TDDS药物局部给药。而前体药物可以在皮肤组织经酶激活,代谢释放出具有活性物质的化合物。该文对目前最新的酶激活前体药物包括解热镇痛抗炎药、抗菌药、抗组胺药、抗肿瘤药、阿片受体拮抗剂、激素等前体药物及其新技术协同给药模式的制备原理、释药机制、存在问题、研究动态等进行归纳总结,并展望未来前体药物开发应用的趋势。酶激活前体药物在经皮给药系统应用中具有特异性、选择性、高透过率等释药特点,其不仅可以增加皮肤对药物的选择性,还能提高药物皮肤透过率,降低药物不良反应,具有良好的应用前景。展开更多
文摘Objectivs Enzyme/prodrug gene therapy provides a potential strategy for the treatment of glioma.Because of the limitations of using viral vectors for clinical application, we investigated the feasibility of cationicamphiphile-mediated enzyme/prodrug gene transfer into C6 glioma cells. Methods Rat C6 glioma cells weretransfected with pUT599plasmid encoding the herpes simplex virus thymidine kinase (HSV-tk) gene via DOTAPand tested for chemosensitivity of prodrug ganciclovir (GCV). To demonstrate in vitro bystander effect, HSV-tkpositive cells were co-cultured with HSV-tk negative cells at varying proportions. Results DOTAP mediatedHSV-tk gene transfer into C6 cells showed 30%-40% of transfection efficiency. HSV-tk infected C6 glioma cellswere rendered sensitive to concentrations of GCV that were 3-4 logs lower than uninfected cells, with an IC05 of0.087μmol/L. In terms of the bystander effect, the viability of co-cultured cells decreased with increasingpopulations of HSV-tk positive cells after GCV treatment. Conclusion C6 cells were successfully transfected withthe HSV-tk gene via cationic amphiphile and displayed a strong bystander effect after GCV treatment. Cationicamphiphile - mediated HSV- tk/GCV chemosensitivity System may have promise as an intratumoral treatment forglioma.
文摘Cancer enzymology is a promising filiation of bio-medical sciences. In thepast decades, enzymes, such as GST(glutathione S-transferase) , PKC(protein kinase C) , Topo(DNAtopoisomerases), TK(tyrosine kinase), CD (bacterial cytosine deaminase), CPG2(carboxypeptidase G2) ,and PNP (purine nucleoside phosphorylase), have been known to bear close relations to cancer. Theirspecific expression and influence on the process of tumor initiation, promotion and progressionattract scientists to apply them as a biochemical marker of certain malignant tumor, a predictor ofresponse in cancer chemotherapy; to apply them to drug design, tumor prevention and as adjuvant toradiotherapy or surgery.
基金This work was supported by the National Natural Science Foundation of China(51773231)Shenzhen Science and Technology Project(JCYJ20190807160801664)the Project of Key Laboratory of Sensing Technology and Biomedical Instruments of Guangdong Province(2011A060901013).
文摘The enzyme-mediated elevation of reactive oxygen species(ROS)at the tumor sites has become an emerging strategy for regulating intracellular redox status for anticancer treatment.Herein,we proposed a camouflaged bionic cascaded-enzyme nanoreactor based on Ti_(3)C_(2)nanosheets for combined tumor enzyme dynamic therapy(EDT),phototherapy and deoxygenation-activated chemotherapy.Briefly,glucose oxidase(GOX)and chloroperoxidase(CPO)were chemically conjugated onto Ti_(3)C_(2)nanosheets,where the deoxygenation-activated drug tirapazamine(TPZ)was also loaded,and the Ti_(3)C_(2)-GOX-CPO/TPZ(TGCT)was embedded into nanosized cancer cell-derived membrane vesicles with high-expressed CD47(m_eTGCT).Due to biomimetic membrane camouflage and CD47 overexpression,m_eTGCT exhibited superior immune escape and homologous targeting capacities,which could effectively enhance the tumor preferential targeting and internalization.Once internalized into tumor cells,the cascade reaction of GOX and CPO could generate HClO for efficient EDT.Simultaneously,additional laser irradiation could accelerate the enzymic-catalytic reaction rate and increase the generation of singlet oxygen(~1O_(2)).Furthermore,local hypoxia environment with the oxygen depletion by EDT would activate deoxygenation-sensitive prodrug for additional chemotherapy.Consequently,m_eTGCT exhibits amplified synergistic therapeutic effects of tumor phototherapy,EDT and chemotherapy for efficient tumor inhibition.This intelligent cascaded-enzyme nanoreactor provides a promising approach to achieve concurrent and significant antitumor therapy.
基金financially supported by the Shandong Provincial Natural Science Foundation of China(No.ZR2021QC088).
文摘Enzyme prodrug therapies(EPTs)have been intensively explored as attractive approaches to selective activation of systemically administered benign prodrugs by the exogenous enzymes or enzymes expressed at the desired target site,thus achieving localized,site-specific therapeutic effect.Many effective strategies(e.g.,antibody-,viral-,gene-,as well as polymer-directed EPT)have been developed for enzyme localization to locally activate systemically administered benign prodrugs.Nevertheless,intrinsic limitations(e.g.,complex intracellular environment and catalyst instability)make the practical application of EPT strategies a task that presents itself as highly challenging.As a promising alternative to natural enzyme,nanozyme has attracted substantial attention since its discovery in 2007,mainly due to the advantages of robust catalytic activity,high stability,low cost,and facile synthesis.Recently,nanozyme-activated prodrug strategies bring a new opportunity for targeted therapy,referred to as nanozyme-activating prodrug therapies.This review focuses on recently reported nanozyme-activated prodrug strategies,aiming to provide some new insights into the potential applications in site-specific drug synthesis.
基金the China Scholarship Council for a personal financial grant(no.201606200045)supported by the European Research Council via a Starting GrantDutch Research Council(NWO)for a VICI grant to S.Bonnet.
文摘Gold complexes have emerged as promising anticancer metallodrugs due to their efficient thioredoxin reductase(TrxR)inhibition,which disturbs the redox balance of cancer cells.However,in this model,the role of the ligand(s)coordinated to gold is often overlooked.In this work,we present a series of tetrapyridyl Au(Ⅲ)complexes that exhibit thiol-induced release of a Au(Ⅰ)ion and a tetrapyridyl ligand.The formation of a free Au(Ⅰ)center is responsible for the expected TrxR inhibition.Additionally,the released ligand,which was visible in cells due to its intense blue fluorescence,showed excellent binding properties to the hERG potassium channel.Moreover,these ligands ended up in the lysosomes,resulting in significant lysosome damage.Altogether,the Au(Ⅲ)complexes presented in this work showed broad-spectrum anticancer properties,both in hypoxic 2D monolayers and 3D tumor spheroids.We suggest that the interaction of the released Au(Ⅰ)center and the tetrapyridyl ligand with two different protein targets may combine into prodrugs that overcome hypoxia-induced drug deactivation.
文摘多数传统的经皮给药系统(traditional transdermal drug delivery system,TDDS)药物,由于化学稳定性差、油水分配系数不理想等,并不适合作为TDDS药物局部给药。而前体药物可以在皮肤组织经酶激活,代谢释放出具有活性物质的化合物。该文对目前最新的酶激活前体药物包括解热镇痛抗炎药、抗菌药、抗组胺药、抗肿瘤药、阿片受体拮抗剂、激素等前体药物及其新技术协同给药模式的制备原理、释药机制、存在问题、研究动态等进行归纳总结,并展望未来前体药物开发应用的趋势。酶激活前体药物在经皮给药系统应用中具有特异性、选择性、高透过率等释药特点,其不仅可以增加皮肤对药物的选择性,还能提高药物皮肤透过率,降低药物不良反应,具有良好的应用前景。
